US Bancorp’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
US Bancorp's OCDX Position: Q2 2022 in Review
US Bancorp sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 493 shares — an estimated $9K sold.
US Bancorp first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- US Bancorp reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
- US Bancorp sold 493 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $9K.
- US Bancorp first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
- US Bancorp's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $9K in Q1 2022.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.
Based on US Bancorp's 13F filing for Q2 2022, filed 1 Aug 2022.